Oruka Therapeutics stock surges as ORKA-001 psoriasis trial success puts $1.1bn biotech strategy to the test
Read More Healthcare Industry News Triton Pacific Healthcare Partners sells BioMatrix Specialty Infusion Pharmacy to Frazier Healthcare Partners Triton Pacific Healthcare Partners, a notable healthcare-focused private equity group, has successfully concluded the sale of BioMatrix Specialty… byPallavi MadhirajuJune 25, 2024